Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 13.835\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) COc1ccccc1CCC(=O)OCC(=O)c1c(N)n(CC(C)C)c(=O)n(C)c1=O
b.) CCCNC(=O)NC(=O)CSc1nnc(-c2c[nH]c3ccccc23)o1
c.) CCCC(c1nnnn1Cc1ccccc1)N1CCC(C(N)=O)CC1.Cl
d.) Cc1ccc(S(=O)(=O)N2CCN(c3ncccn3)CC2)c(C)c1
e.) Cc1ccc2cc(CCNS(=O)(=O)c3ccc(Br)cc3)c(=O)[nH]c2c1C
Answer: b. CCCNC(=O)NC(=O)CSc1nnc(-c2c[nH]c3ccccc23)o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)NC(=O)CSc1nnc(-c2c[nH]c3ccccc23)o1
CCCNC(=O)NC(=O)CSc1nnc(-c2c[nH]c3ccccc23)o1
2-[[5-(1H-indol-3-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(propylcarbamoyl)acetamide